Form 4 Filing: Ostrovsky Maria Acquires (Grant) shares of $CADL

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

Candel Therapeutics, Inc.

Ticker: $CADL

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-03

Shares: 315,000

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ostrovsky Maria, holds the title of General Counsel at Candel Therapeutics, Inc..

On 2026-11-03, the insider transacted 315,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Ostrovsky Maria (General Counsel) was granted $0 of $CADL

Post-Transaction Position: 315,000 shares

SEC Accession No: 0001193125-26-449949 (CIK: 2160227)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$CADL Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$CADL News Coverage